U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H29NO3.C4H4O4
Molecular Weight 531.5962
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZAMIFENACIN FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.C(CC1=CC2=C(OCO2)C=C1)N3CCC[C@H](C3)OC(C4=CC=CC=C4)C5=CC=CC=C5

InChI

InChIKey=PMHKTAIGYOVZEZ-ZHWJIHCSSA-N
InChI=1S/C27H29NO3.C4H4O4/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25;5-3(6)1-2-4(7)8/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2;1-2H,(H,5,6)(H,7,8)/b;2-1+/t24-;/m1./s1

HIDE SMILES / InChI

Description

Zamifenacin, also known as UK-76654, a selective muscarinic M3 receptor antagonist, was studied in patients with irritable bowel syndrome (IBS). This drug participated in clinical trials for the IBS phase III in the USA and phase II in the UK, but these studies were discontinued.

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Muscarinic acetylcholine receptor M3
159
Target ID: P20309
Gene ID: 1131.0
Gene Symbol: CHRM3
Target Organism: Homo sapiens (Human)
Antagonist
2778
 8.52 null [pKi]
PubMed

PubMed

TitleDatePubMed
Patents

Patents

20050004155
2
JPH07157469A
2

Sample Use Guides

In Vivo Use Guide
single dose of zamifenacin 10 mg or 40 mg on both fasting (30 min) and fed (60 min)
Route of Administration: Oral
Name Type Language
ZAMIFENACIN FUMARATE
Common Name English
UK-76654-2
Code English
PIPERIDINE, 1-(2-(1,3-BENZODIOXOL-5-YL)ETHYL)-3-(DIPHENYLMETHOXY)-, (3R)-, (2E)-2-BUTENEDIOATE (1:1)
Systematic Name English
(R)-3-(BENZHYDRYLOXY)-1-(2-(BENZO(D)(1,3)DIOXOL-5-YL)ETHYL)PIPERIDINE FUMARATE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID9049037
Created by admin on Sat Dec 16 08:30:17 GMT 2023 , Edited by admin on Sat Dec 16 08:30:17 GMT 2023
PRIMARY
PUBCHEM
60196362
Created by admin on Sat Dec 16 08:30:17 GMT 2023 , Edited by admin on Sat Dec 16 08:30:17 GMT 2023
PRIMARY
CAS
127308-98-9
Created by admin on Sat Dec 16 08:30:17 GMT 2023 , Edited by admin on Sat Dec 16 08:30:17 GMT 2023
PRIMARY
FDA UNII
YCS9BM2UNR
Created by admin on Sat Dec 16 08:30:17 GMT 2023 , Edited by admin on Sat Dec 16 08:30:17 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of ZAMIFENACIN
SUBSTANCE RECORD
Structure of ZAMIFENACIN FUMARATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966